Canada markets closed

ImmunoGen, Inc. (IMU.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.2215+0.1220 (+2.98%)
At close: 08:01AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
92,228
69,856
132,299
82,271
53,446
Cost of Revenue
-
-
114,592
114,522
174,456
Gross Profit
-
-
17,707
-32,251
-121,010
Operating Expenses
Research Development
160,986
151,117
114,592
114,522
174,456
Selling General and Administrative
50,251
43,812
38,600
38,489
36,746
Total Operating Expenses
211,237
194,929
153,192
153,011
211,202
Operating Income or Loss
-119,009
-125,073
-20,893
-70,740
-157,756
Interest Expense
9,731
13,150
23,202
16,974
10,726
Total Other Income/Expenses Net
-657
-1,080
-277
-16,419
-361
Income Before Tax
-129,397
-139,303
-44,372
-104,133
-168,843
Income from Continuing Operations
-129,397
-139,303
-44,372
-104,133
-168,843
Net Income
-129,397
-139,303
-44,372
-104,133
-168,843
Net Income available to common shareholders
-129,397
-139,303
-44,372
-104,133
-168,843
Basic EPS
-
-0.68
-0.25
-0.70
-1.20
Diluted EPS
-
-0.68
-0.25
-0.70
-1.20
Basic Average Shares
-
206,147
176,153
148,311
139,946
Diluted Average Shares
-
206,147
176,153
148,311
139,946
EBITDA
-
-124,136
-19,069
-83,131
-150,706